97
Participants
Start Date
May 31, 2011
Primary Completion Date
August 31, 2015
Study Completion Date
November 30, 2015
BMAC injection
Injection of 40 ml of autologous bone marrow aspirate concentrate (BMAC injection) prepared with the SmartPReP2 BMAC System
Placebo injection
Injection of placebo into ischemic tissue of the lower extremity
St. Luke's Roosevelt, New York
North Shore-Long Island Jewish, Lake Success
Johns Hopkins Hospital, Baltimore
Charleston Area Medical Center Institute, Charleston
Wake Forest Baptist Health, Winston-Salem
University of North Carolina at Chapel Hill, Chapel Hill
Roper St Francis Medical Center, Charleston
Greenville Health System, Greenville
Coastal Vascular & Interventional, Pensacola
Florida Hospital - Vascular Institute of Central Florida, Orlando
USF / Tampa General, Tampa
University of Tennessee, Knoxville
University of Cincinnati, Cincinnati
Regional Infectious Disease and Infusion Ctr, Lima
Cadence Health, Central DuPage Hospital, Winfield
University of Illinois-Chicago, Chicago
Mercy Hospital, St Louis
Kansas City Vascular, Kansas City
Ochsner Clinic, New Orleans
Medical Center of South Arkansas, El Dorado
University of Oklahoma, Tulsa
Baylor Medical Ctr, Dallas
University of Texas - Houston Medical School, Houston
USC Keck School of Medicine, Los Angeles
Oregon Health Science University, Portland
Peace Health Southwest Medical Center, Vancouver
University of Alabama, Birmingham
Maine Medical Ctr, Portland
Tufts Medical Center, Boston
Beth Israel Deaconess, Boston
Dartmouth Hitchcock Medical Ctr, Lebanon
Cooper University Hospital, Camden
Holy Name Medical Center, Teaneck
Rhode Island Hospital, Providence
Lead Sponsor
Harvest Technologies
INDUSTRY